The Loblaw Companies Limited conglomerate announced plans to merge with pharmacy and grocery store chain Shoppers Drug Mart Corporation in a deal worth nearly $12 billion, according to a press release. Reports say the buyout will allow Loblaw to step into the market of small-urban stores, while Shoppers Drug Mart will continue to operate independently under its own name. The plans remain subject to shareholder and regulatory approval. The deal has not come without resistance, however, as some have speculated what the merger would mean for consumers in Canada, say reports.
Featured News
CFTC Moves To East Reporting Requirements for Prediction Markets
May 16, 2026 by
CPI
California’s Settlement With GM Signals Closer Scrutiny of Data Sales
May 16, 2026 by
CPI
Jury in Boston Set to Decide Takeda’s Fate in Amitiza Antitrust Trial
May 14, 2026 by
CPI
OnlyFans Faces New Antitrust Lawsuit
May 14, 2026 by
CPI
Americans’ Opposition to Hosting AI Data Centers Hardens, Survey Finds
May 14, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Unilateral Effects
Apr 28, 2026 by
CPI
A Net Present Value Approach to Merger Analysis
Apr 28, 2026 by
Joseph J Simons & Malcolm Coate
Generative AI and Competitive Disruption: Increasingly Relevant for Merger Analysis?
Apr 28, 2026 by
Andrea Coscelli, Emily Chissell, Nitika Bagaria & Tega Akati-Udi
Non-Price Unilateral Effects In Media Mergers
Apr 28, 2026 by
Lapo Filistrucchi & Teresa Oriani
Ecosystem Mergers and Unilateral Effects? A Framework for Assessing the Ecosystem Theory of Harm
Apr 28, 2026 by
Ethel Fonseca, George Tucker & Helder Vasconcelos